Synonym
Wy 26392; Wy26392; Wy-26392
IUPAC/Chemical Name
N-[(11bR)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]-N-methylpropane-1-sulfonamide;hydrochloride
InChi Key
PAXYOGKTTMRRMP-PKESZJFOSA-N
InChi Code
InChI=1S/C17H26N2O2S.ClH/c1-3-12-22(20,21)18(2)15-9-11-19-10-8-14-6-4-5-7-16(14)17(19)13-15;/h4-7,15,17H,3,8-13H2,1-2H3;1H/t15?,17-;/m1./s1
SMILES Code
CCCS(=O)(N(C1CCN2CCC3=CC=CC=C3[C@@]2([H])C1)C)=O.[H]Cl
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
358.93
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Paciorek PM, Pierce V, Shepperson NB, Waterfall JF. An investigation into the selectivity of a novel series of benzoquinolizines for alpha 2-adrenoceptors in vivo. Br J Pharmacol. 1984 May;82(1):127-34. PubMed PMID: 6329385; PubMed Central PMCID: PMC1987241.
2: Ramage AG, Tomlinson A. The effect of yohimbine, WY 26392 and idazoxan on sympathetic nerve activity. Eur J Pharmacol. 1985 Feb 26;109(2):153-60. PubMed PMID: 2859996.
3: Ramage AG. The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors. Br J Pharmacol. 1991 Apr;102(4):998-1002. PubMed PMID: 1855130; PubMed Central PMCID: PMC1917978.
4: Jurcovicová J, Le T, Krulich L. The paradox of alpha 2 adrenergic regulation of prolactin (PRL) secretion. II. PRL-releasing action of the alpha 2 receptor antagonists. Brain Res Bull. 1989 Dec;23(6):425-32. PubMed PMID: 2575440.
5: Fozard JR, Mir AK, Middlemiss DN. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol. 1987 Mar;9(3):328-47. PubMed PMID: 2437400.
6: Bill DJ, Hughes IE, Stephens RJ. The thermogenic actions of alpha 2-adrenoceptor agonists in reserpinized mice are mediated via a central postsynaptic alpha 2-adrenoceptor mechanism. Br J Pharmacol. 1989 Jan;96(1):133-43. PubMed PMID: 2564288; PubMed Central PMCID: PMC1854293.
7: Hamilton CA, Reid JL, Yakubu MA. [3H]yohimbine and [3H]idazoxan bind to different sites on rabbit forebrain and kidney membranes. Eur J Pharmacol. 1988 Feb 9;146(2-3):345-8. PubMed PMID: 3371405.
8: Berthold H, Fozard JR, Engel G. 5-HT1 receptor agonists attenuate the naloxone-induced jumping behaviour in morphine-dependent mice. Eur J Pharmacol. 1989 Mar 14;162(1):19-27. PubMed PMID: 2566495.
9: Dickinson KE, McKernan RM, Miles CM, Leys KS, Sever PS. Heterogeneity of mammalian alpha 2-adrenoceptors delineated by [3H]yohimbine binding. Eur J Pharmacol. 1986 Jan 29;120(3):285-93. PubMed PMID: 3005004.
10: Gower AJ, Tricklebank MD. Alpha 2-adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat. Eur J Pharmacol. 1988 Oct 11;155(1-2):129-37. PubMed PMID: 2907485.
11: Shepperson NB. Alpha 2-adrenoceptor agonists potentiate responses mediated by alpha 1-adrenoceptors in the cat nictitating membrane. Br J Pharmacol. 1984 Oct;83(2):463-9. PubMed PMID: 6148985; PubMed Central PMCID: PMC1987131.
12: McKernan RM, Dickinson KE, Miles CM, Sever PS. Heterogeneity between soluble human and rabbit splenic alpha 2-adrenoceptors. Biochem Pharmacol. 1986 Oct 15;35(20):3517-23. PubMed PMID: 2876709.
13: Oyekan AO, Botting JH. Adrenaline inhibits adenosine diphosphate induced intravascular aggregation of rat platelets through stimulation of alpha 2 adrenoceptors. Cardiovasc Res. 1991 May;25(5):431-7. PubMed PMID: 1677313.
14: McAdams RP, Waterfall JF. The effect of age on the sensitivity of pre- and postsynaptic alpha-adrenoceptors to agonists and antagonists in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):430-5. Erratum in: Naunyn Schmiedebergs Arch Pharmacol 1987 Apr;335(4):480. PubMed PMID: 2881219.
15: Lattimer N, McAdams RP, Rhodes KF, Sharma S, Turner SJ, Waterfall JF. Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1984 Oct;327(4):312-8. PubMed PMID: 6151116.
16: Paciorek PM, Shepperson NB. alpha 1-Adrenoceptor agonist activity of alpha 2-adrenoceptor antagonists in the pithed rat preparation. Br J Pharmacol. 1983 May;79(1):12-4. PubMed PMID: 6135473; PubMed Central PMCID: PMC2044847.
17: Botting JH, Oyekan AO, Hammady F. Inhibition of intravascular platelet aggregation in the rat by adrenaline. Pol J Pharmacol Pharm. 1990 May-Jun;42(3):291-9. PubMed PMID: 2263536.
18: Waterfall JF, Rhodes KF, Lattimer N. Studies of alpha 2-adrenoceptor antagonist potency in vitro: comparisons in tissues from rats, rabbits, dogs and humans. Clin Sci (Lond). 1985;68 Suppl 10:21s-24s. PubMed PMID: 2857614.
19: Paciorek PM, Shepperson NB. The alpha 2-adrenoceptor selectivities and haemodynamic effects of WY26392 and yohimbine in the anaesthetised dog. Eur J Pharmacol. 1985 Apr 2;110(2):191-201. PubMed PMID: 2859215.
